Novel xanthine oxidase inhibitors as a therapeutic agent or a preventive agent for gout and hyperuricemia

被引：0
|
作者：
Kawana, Asahi [1 ]
Kanazawa, Chikashi [1 ]
Takahashi, Yoshimasa [1 ]
Muroga, Yumiko [1 ]
Imazeki, Mariko [1 ]
Nakada, Yoshio [1 ]
机构：
[1] Teijin Pharma Ltd, Hino, Tokyo, Japan
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 250卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
139
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Febuxostat: A Novel Agent for Management of Hyperuricemia in Gout
    Bisht, Manisha
    Bist, S. S.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 73 (06) : 597 - 600
  • [2] 3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: A potential therapeutic agent for treatment of hyperuricemia and gout
    Lue, Jian-Ming
    Yao, Qizhi
    Chen, Changyi
    BIOCHEMICAL PHARMACOLOGY, 2013, 86 (09) : 1328 - 1337
  • [3] THE THERAPEUTIC EFFICACY OF THE NOVEL URICOSURIC AGENT UR-1102 FOR HYPERURICEMIA AND GOUT
    Ahn, S. O.
    Horiba, N.
    Ohtomo, S.
    Lee, K. J.
    Kim, K. H.
    Kim, B. H.
    Kiyokawa, J.
    Yamane, M.
    Ikegami, H.
    Nakagawa, T.
    Hwang, H. -H.
    Park, J. -H.
    Cha, J. Y.
    Tanaka, J.
    Kake, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 704 - 704
  • [4] Investigation of resveratrol as a xanthine oxidase inhibitor: Mechanistic insights and therapeutic implications for gout and hyperuricemia
    Chen, Jianmin
    Chen, Juan
    Feng, Baozhu
    Ning, Meilian
    Wu, Wanhui
    Zou, Shiqi
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2024,
  • [5] An updated patent review: xanthine oxidase inhibitors for the treatment of hyperuricemia and gout (2011-2015)
    Ojha, Ritu
    Singh, Jagjeet
    Ojha, Anu
    Singh, Harbinder
    Sharma, Sahil
    Nepali, Kunal
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2017, 27 (03) : 311 - 345
  • [6] Febuxostat: A selective xanthine oxidase inhibitor for the treatment of hyperuricemia and gout
    Bruce, Susan P.
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (12) : 2187 - 2194
  • [7] EFFECTS OF A XANTHINE OXIDASE INHIBITOR ON THIOPURINE METABOLISM, HYPERURICEMIA AND GOUT
    RUNDLES, RW
    WYNGAARDEN, JB
    HITCHINGS, GH
    ELION, GB
    SILBERMAN, HR
    TRANSACTIONS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, 1963, 76 : 126 - 140
  • [8] Febuxostat: A Novel Non-Purine Selective Inhibitor of Xanthine Oxidase for the Treatment of Hyperuricemia in Gout
    Yu, Kuang-Hui
    RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY, 2007, 1 (01) : 69 - 75
  • [9] TMX-67 -: Treatment of gout and hyperuricemia -: Xanthine oxidase inhibitor
    Sorbera, LA
    Revel, L
    Rabasseda, X
    Castañer, J
    DRUGS OF THE FUTURE, 2001, 26 (01) : 32 - 38
  • [10] An Overview on the Role of Xanthine Oxidase Inhibitors in Gout Management
    Alghamdi, Adnan Ali
    Althumali, Jameel Sami
    Mohammed, M. Almalki Meshal
    Almasoudi, Ahmad Saeed
    Almuntashiri, Ali Hussain
    Almuntashiri, Abdulaziz Hassan
    Mohammed, Alkhrizi Ibrahim
    Alkinani, Ashraf Ali
    Almahdawi, Meshari Saeed
    Hussain, M. Mahzari Ali
    ARCHIVES OF PHARMACY PRACTICE, 2021, 12 (03) : 94 - 99
12345